FDA Adverse Event Malfunction Summary report: N

SYNERGY¿

MDR report key: 6130257 · Received November 28, 2016

Report

Report Number
2134265-2016-10751
Event Type
Malfunction
Date Received
November 28, 2016
Date of Event
November 6, 2016
Report Date
November 7, 2016
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
SIMILAR
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AGE AT TIME OF EVENT: 18 YEARS OR OLDER. DEVICE IS A COMBINATION PRODUCT. (B)(4).

Additional Manufacturer Narrative · 1

DEVICE EVALUATED BY MFR.: THE STENT DELIVERY SYSTEM (SDS) WAS RETURNED FOR ANALYSIS. A VISUAL EXAMINATION OF THE CRIMPED STENT FOUND NO ISSUES WITH THE STENT. THERE WERE NO SIGNS OF DAMAGE, STRETCHING OR LIFTING OF THE STENT STRUTS. THE STENT SHOWED NO SIGNS OF MOVEMENT AND WAS SET EQUIDISTANT BETWEEN THE PROXIMAL AND DISTAL MARKERBANDS. THE UNDAMAGED PROXIMAL STENT OD (OUTER DIAMETER) WAS MEASURED AND IS WITHIN MAXIMUM CRIMPED STENT SPECIFICATION. THE BALLOON CONES WERE REVIEWED AND NO ISSUES WERE NOTED. THE BALLOON WINGS WERE TIGHTLY WRAPPED AND EVENLY FOLDED AND WERE NOT SUBJECTED TO POSITIVE PRESSURE. BASED ON THE EVENT DESCRIPTION, THE BALLOON RUPTURED, HOWEVER NO EVIDENCE OF DAMAGE WAS OBSERVED ON THE BALLOON. THE DELIVERY CATHETER WAS CONNECTED TO AN ENCORE INFLATION DEVICE AND AN ATTEMPT WAS MADE TO APPLY POSITIVE PRESSURE TO THE BALLOON CHAMBER; HOWEVER THE DEVICE LEAKED AT THE PORT WELD SITE. THE BUMPER TIP OF THE DEVICE SHOWED SLIGHT SIGNS OF DAMAGE TO THE DISTAL EDGE OF THE TIP. THIS TYPE OF DAMAGE IS CONSISTENT WITH RESISTANCE BEING ENCOUNTERED ON ADVANCEMENT OF THE STENT DELIVERY CATHETER TO THE LESION SITE. A VISUAL AND TACTILE EXAMINATION FOUND MULTIPLE SEVERE KINKS ALONG THE HYPOTUBE SHAFT. THIS TYPE OF DAMAGE IS CONSISTENT WITH EXCESSIVE FORCE BEING APPLIED TO THE DELIVERY SYSTEM. A VISUAL AND TACTILE EXAMINATION OF THE MIDSHAFT FOUND DAMAGE AT THE PORT BOND EXIT SITE. THE HYPOTUBE TAB AT THE BACK OF THE PORT WAS NOTED TO BE INCORRECTLY SEATED DUE TO THE MIDSHAFT BEING TWISTED AT THE PORT SITE. AN ATTEMPT WAS MADE TO INFLATE THE DEVICE DURING EXAMINATION; HOWEVER THE INFLATION FLUID LEAKED THROUGH THE PORT BOND SITE, THUS CONFIRMING THE DAMAGE CONCENTRATED AT THIS LOCATION AND MOST LIKELY OCCURRED DURING PROCEDURE. THE INNER LUMEN, OUTER EXTRUSION AND BI-COMPONENT BOND SHOWED NO SIGNS OF DAMAGE OR STRAIN. NO OTHER ISSUES WERE IDENTIFIED DURING THE PRODUCT ANALYSIS. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE ROOT CAUSE IS NOT CONFIRMED AS THERE WAS NO EVIDENCE OF THE ALLEGED ISSUE OR ANY ANOMALIES WHICH COULD HAVE CONTRIBUTED TO THE REPORTED DIFFICULTY. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE TARGET LESION WAS LOCATED IN THE CORONARY ARTERY. A 2.50 X 20 SYNERGY¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION. HOWEVER, WHEN THE DEVICE WAS POSITIONED AND INITIAL INFLATION OF THE BALLOON WAS ATTEMPTED, THE BALLOON WAS HARD TO INFLATE. THE DEVICE WAS COMPLETELY REMOVED AND THE BALLOON WAS THEN FOUND TO BE RUPTURED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS STABLE.

Description of Event or Problem · 1

IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE TARGET LESION WAS LOCATED IN THE CORONARY ARTERY. A 2.50 X 20 SYNERGY¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION. HOWEVER, WHEN THE DEVICE WAS POSITIONED AND INITIAL INFLATION OF THE BALLOON WAS ATTEMPTED, THE BALLOON WAS HARD TO INFLATE. THE DEVICE WAS COMPLETELY REMOVED AND THE BALLOON WAS THEN FOUND TO BE RUPTURED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
779544 SYNERGY¿ CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - GALWAY H7493926220250 18879802

Patients

Seq Age Sex Outcome Treatment
1